Reuters logo
BRIEF-Vivus reports settlement with Dr. Reddy's laboratories on qsymia patent litigation
August 30, 2017 / 8:12 PM / in 2 months

BRIEF-Vivus reports settlement with Dr. Reddy's laboratories on qsymia patent litigation

Aug 30 (Reuters) - Vivus Inc:

* Vivus announces settlement with Dr. Reddy’s laboratories on qsymia(r) patent litigation

* Vivus Inc - ‍settlement permits Dr. Reddy’s to begin selling a generic version of qsymia on June 1, 2025, or earlier under certain circumstances​

* Vivus - ‍in event of a launch earlier than June 1, 2025, Vivus will receive a royalty on sales of generic version of qsymia​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below